Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) — The “Cattle & Porcine/Swine Reproductive Diseases Market by Product (Diagnostics (ELISA, PCR, Rapid Antigen Testing), Pharmaceuticals (Vaccines), Supplements, Animal Type, Disease (BVD, PRRS, Leptospirosis, Brucellosis), End User – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global cattle & porcine/swine reproductive diseases market is projected to reach USD 975.8 million by 2029 from USD 758.2 million in 2024 at a CAGR of 5.2%.
Between January 2021 and August 2024, major players in this market adopted various strategies to expand their global presence and increase market share. These tactics include entering into strategic agreements, divestitures, expanding operations, and acquiring other companies.
These efforts aim to enhance product portfolios, improve efficiency, and tap into new regional markets. The competitive landscape illustrates the industry’s focus on meeting the rising demand for reproductive disease treatments in cattle and pigs, which is crucial for supporting the global livestock sector.
The Pharmaceutical segment is expected to grow at the second highest CAGR
By product type, the pharmaceuticals segment represents the second highest CAGR in the cattle & porcine/swine reproductive diseases market. This is mainly due to some crucial factors. Advancements in the manufacturing of vaccines, such as the development of more effective formulations and sustainable production practices, have a great influence on market growth.
The demand for the above-mentioned pharmaceutical products has increased due to the growing incidence of reproductive diseases in farm animals. The development of diagnostic tools supplements the application of vaccines and antibiotics, enabling timely and efficient disease detection. These two innovations, along with other improvements in their efficacy, have strongly supported the top market position of the pharmaceuticals segment.
Bovine Viral Diarrhea (BVD) segment witnessed the second-highest CAGR
BVD is expected to be the second fastest-growing segment in terms of CAGR in the cattle & porcine/swine reproductive diseases market during the forecast period. Several factors have contributed to this growth: first, BVD affects several million cattle worldwide, resulting in marked economic losses due to reduced milk production and poor meat quality.
Further, the various symptoms and complications of the disease necessitate a fitting response on the part of farmers and veterinarians. Increased regulatory focus, besides active initiatives by the industry for control and eradication of BVD, also drives the market. As such efforts start turning more concentrated and fruitful, solutions and services directed at overcoming BVD further amplify the demand for the same, thereby fueling market growth.
The Porcine segment accounted for the second largest market share
Based on animal type, the porcine segment accounted for the second largest market share in the cattle & porcine/swine reproductive diseases market because of high economic impact of diseases like Porcine Reproductive and Respiratory Syndrome (PRRS) on pig farms drives significant spending on management and prevention. Second, the global rise in pork consumption and intensive pig farming practices increase the risk of disease spread, highlighting the need for effective disease control.
Lastly, ongoing research works in vaccine and treatment options for porcine diseases boost market growth by offering better solutions to manage and prevent outbreaks. As pork production continues to expand, the focus on controlling reproductive diseases in pigs remains a high priority, further driving market demand.
Veterinary hospitals and clinics segment is expected to witness the second highest CAGR
By end user, veterinary hospitals & clinics are expected to record the second-highest CAGR in the cattle & porcine/swine reproductive diseases market during the forecast period. Several factors contribute to such significant growth. Veterinary hospitals & clinics provide a place of advanced diagnostics and treatments essential for such specialized care, especially in reproductive problems in livestock.
Due to this realization, farmers view these facilities as a source of expert medical services, thus making them seek accurate disease detection and a definite treatment plan. Besides this, increasing awareness concerning regular visits to veterinary institutes has also made farmers rely more on such institutions for preventive as well as curative purposes. The quality and customized services offered by veterinary clinics and hospitals contribute considerably to their popularity in the market.
North America expected to have the second highest CAGR in the cattle & porcine/swine reproductive diseases market
In the North America region, the cattle & porcine/swine reproductive diseases market has grown significantly. The region’s extensive cattle and pig farms drive a significant demand for reproductive health products and services. This demand is supported by well-established veterinary research institutions that foster innovation and advancements in disease management.
Furthermore, strong government support and funding for animal health initiatives in countries such as the US and Canada enhance the market’s robustness. The emphasis on boosting livestock productivity and upholding high standards of animal welfare also strengthens the region’s position in the global market.
Research Coverage
The market analysis examines the cattle & porcine/swine reproductive diseases market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product type, disease type, animal type, end user type and geography. The study also includes a detailed competitive analysis of the market’s top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Market Players
The prominent players in the cattle & porcine/swine reproductive diseases market include Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmBH (Germany), Virbac (France), Elanco Animal Health Incorporated (US), Vetoquinol S.A. (France), Ceva Sante Animale (France), Idexx Laboratories (US), Thermo Fisher Scientific Inc. (US), Biochek Smart Veterinary Diagnostics (Netherlands), Ring Biotechnology Co Ltd. (China), Sequent Scientific Limited (India), Hipra (Spain), Qiagen N.V. (Germany), Innovative Diagnostics (France), Colorado Serum Company (US), Indian Immunologicals Ltd (US), Refit Animal Care (India), Calier (US), Megacor Diagnostik GmbH (Austria), Vetanco (Brazil), Biogenesis Bago (Argentina), Advacare Pharma (US), Bio-X Diagnostics S.A. (Belgium), and Pax Healthcare (India).
Key Attributes
| Report Attribute | Details |
| No. of Pages | 334 |
| Forecast Period | 2024-2029 |
| Estimated Market Value (USD) in 2024 | $758.2 Million |
| Forecasted Market Value (USD) by 2029 | $975.8 Million |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
Market Dynamics
- Drivers
- Growing Demand for Animal-Derived Food Products
- Increasing Prevalence of Reproductive Health Issues
- Rising Number of Veterinary Practitioners in Developed Markets
- Increasing Per Capita Income of Farmers in Emerging Markets
- Restraints
- Limited Awareness & Education Among Small-Scale Farmers
- Opportunities
- Advancements in Veterinary Healthcare
- High Growth Potential of Emerging Economies
- Challenges
- Stringent Regulatory Guidelines for Livestock Industry
Industry Trends
- Increasing Adoption of Vaccination Programs
- Emphasis on Sustainable Practices
Technology Analysis
- Key Technologies
- Vaccination Technologies
- Diagnostic Tools
- Complementary Technologies
- Genomic Selection & Breeding
- Precision Livestock Farming
- Adjacent Technologies
- Nutritional Supplements & Additives
- Integration of Livestock Management Software
Case Study Analysis
- Innovation in Bovine Reproductive Disease Vaccination
- Tech-Driven Solutions for Livestock Reproductive Health
- Integrated Health Solutions for Cattle Reproductive Health
Further Analyses in the Report
- Supply Chain Analysis
- Value Chain Analysis
- Adjacent Markets for Cattle & Porcine Reproductive Diseases Market
- Trends/Disruptions Impacting Customer’s Businesses
- Investment & Funding Scenario
- Reimbursement Analysis
- Key Conferences and Events
- Unmet Needs/End-user Expectations in Cattle & Porcine Reproductive Diseases Market
- Impact of Gen AI on Cattle & Porcine Reproductive Diseases Market
- Ecosystem Analysis
- Key Stakeholders and Buying Criteria
- Regulatory Landscape
- Patent Analysis
- Trade Analysis
- Pricing Analysis
For more information about this report visit https://www.researchandmarkets.com/r/5bvr02
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Cattle & Porcine/Swine Reproductive Diseases Market
